On May 4, 2010
A Plan So Crazy It Just Didn’t Work: How J&J Got Busted Selling an Epilepsy Drug as a Weight-Loss Product
Just when you think you’ve seen every crazy scheme that drug companies use to push pharmaceuticals for unlawful “off-label” purposes, along comes a new one: Johnson & Johnson (JNJ)’s $81 million settlement for its mismarketing of the epilepsy drug Topamax.
…
0 Comments